Tiam2-related activators encompass a group of chemicals that indirectly influence the activity of Tiam2 by modulating associated signaling pathways. Tiam2, as a guanine nucleotide exchange factor, primarily activates Rho-like GTPases, especially Rac1, playing a key role in regulating cell morphology, migration, and adhesion. The chemicals listed target various aspects of the Rho/Rac/Cdc42 pathways and other interconnected signaling networks. For instance, inhibitors of Rac1 (like NSC23766 and EHop-016) and Cdc42 (such as XL413) may create a feedback mechanism that affects Tiam2's regulation of these GTPases.
In addition to targeting GTPases directly, some compounds, like statins (Lovastatin and Simvastatin), and kinase inhibitors (Tozasertib, Y-27632) modulate the broader signaling landscape in which Tiam2 operates. By influencing pathways like ERK, PI3K, and mTOR, these compounds can indirectly affect the cellular processes governed by Tiam2. This indirect modulation can be crucial for understanding and manipulating Tiam2's role in various biological contexts, including its implications in cell migration. The study of Tiam2 and its associated pathways is complex, and the interaction of these chemicals with Tiam2-related signaling is a subject of ongoing research. The use of these compounds provides a tool for dissecting the intricate signaling networks and understanding the physiological and pathological roles of Tiam2. However, the precise effects and mechanisms of action require further experimental validation and exploration in relevant biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $78.00 | ||
Targets Rac1; by modulating Rac1, it may indirectly influence Tiam2 activity. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
As a statin, it impacts Rho/Rac/Cdc42 pathways, potentially influencing Tiam2's regulatory network. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Similar to Lovastatin, affects Rho/Rac/Cdc42 pathways, potentially impacting Tiam2 signaling. | ||||||
XL413 | 1169562-71-3 | sc-474909 | 5 mg | $275.00 | ||
A Cdc42 inhibitor, which could indirectly affect Tiam2's role in GTPase signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects GSK-3β and related signaling, potentially influencing pathways connected to Tiam2. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor, potentially affecting downstream effects of Tiam2-related GTPase signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, potentially impacting Tiam2-related signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which could indirectly affect signaling pathways associated with Tiam2. | ||||||